$ 825.0
Quantity: 50mg
In stock
Description
Product name: GSB-106
Catalog#: 1805032
Synonyms: bis-(N-monosuccinyl-l-seryl-l-lysine) hexamethylenediamide (GSB-106),
M.W: 746.85
M.F.: C32H58N8O12
Purity: 95%
Counter ion: Trifluoacetate
Format: Lyophilized powder
Description: A low-molecular-weight mimetic GSB-106, which is a substituted dimeric dipeptide bis(N-monosuccinyl-L-seryl-L-lysine)hexamethylenediamide, was designed and synthesized based on the BDNF fourth loop structure at the V.V. Zakusov Institute of Pharmacology (RAMS). In vivo experiments revealed significant antidepressant properties of GSB-106 in doses of 0.1-10 mg/kg (intraperitoneally and orally). Effects of GSB-106 on hippocampal neurogenesis were studied in mice subjected to chronic predator stress. Proliferative activity in the subgranular zone of the dental gyrus was assessed immunohistochemically by Ki-67 expression (a marker of dividing cells). It was found that GSB-106 (10 mg/kg, intraperitoneally, 5 days) completely prevents neurogenesis disturbances in stressed mice. These findings suggest that GSB-106 is a promising candidate for the development of antidepressant agents with BDNF-like mechanism of action.
Usage: For Scientific Research Use Only, Not for Human Use.
